Spyre Therapeutics Investor
Preclinical stage biotechnology companySpyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease ( Therapeutics, Inc. (SYRE) & Overview - /?
Headquarters:
Waltham, MA, US
Employee Number:
30
Founded Date:
2013.0
